Pacific Edge Limited (PFGTF) has released an update.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Pacific Edge Limited reports a steady performance for the six months ending in September 2024, despite challenges posed by Medicare uncertainties. The company’s operating revenue increased slightly, with promising developments in securing Medicare coverage for its Cxbladder tests and advancing new product launches. With a strong cash reserve, Pacific Edge remains focused on maintaining profitability and expanding its market presence.
For further insights into PFGTF stock, check out TipRanks’ Stock Analysis page.